Peculiarities of the COVID-19 course and consequences in overweight and obese patients. Lessons from the current pandemic
Treatment difficulties of COVID-19 have determined the need to identify predictive risk factors for the development of a complicated disease course, critical conditions and death. Endocrine and metabolic abnormalities associated with obesity, including impaired insulin sensitivity, chronic inflammat...
Main Authors: | T. Yu. Demidova, E. I. Volkova, E. Yu. Gritskevich |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2020-12-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/12663 |
Similar Items
-
Immunometabolism and metainflammation in obesity
by: Tatiana R. Romantsova, et al.
Published: (2019-12-01) -
Functional brain MRI in the setting of drug correction of obesity
by: P. I. Kuznetsova, et al.
Published: (2022-05-01) -
Sibutramine: Myths and Realities
by: Marina Olegovna Galieva, et al.
Published: (2014-12-01) -
Rational approach to patients treatment with type 2 diabetes and obesity: results of the All-Russian observational program «AURORA»
by: Ivan I. Dedov, et al.
Published: (2018-12-01) -
Sibutramine: efficacy and safety of prescribing in routine clinical practice
by: Tat'yana Ivanovna Romantsova
Published: (2015-11-01)